Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
AMED logo AMED
Upturn stock ratingUpturn stock rating
AMED logo

Amedisys Inc (AMED)

Upturn stock ratingUpturn stock rating
$97.92
Last Close (24-hour delay)
Profit since last BUY3.62%
upturn advisory
Consider higher Upturn Star rating
BUY since 44 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/27/2025: AMED (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

11 Analysts rated it

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Year Target Price $96.17

Year Target Price $96.17

Analyst’s Price TargetsFor last 52 week
$96.17Target price
Low$82.15
Current$97.92
high$98.95

Analysis of Past Performance

Type Stock
Historic Profit -0.56%
Avg. Invested days 51
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/27/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 3.21B USD
Price to earnings Ratio 36.13
1Y Target Price 97.38
Price to earnings Ratio 36.13
1Y Target Price 97.38
Volume (30-day avg) -
Beta 0.94
52 Weeks Range 82.15 - 98.95
Updated Date 06/29/2025
52 Weeks Range 82.15 - 98.95
Updated Date 06/29/2025
Dividends yield (FY) -
Basic EPS (TTM) 2.71

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 3.79%
Operating Margin (TTM) 10.11%

Management Effectiveness

Return on Assets (TTM) 6.36%
Return on Equity (TTM) 7.15%

Valuation

Trailing PE 36.13
Forward PE 21.37
Enterprise Value 3381487345
Price to Sales(TTM) 1.35
Enterprise Value 3381487345
Price to Sales(TTM) 1.35
Enterprise Value to Revenue 1.43
Enterprise Value to EBITDA 14.06
Shares Outstanding 32819600
Shares Floating 32175060
Shares Outstanding 32819600
Shares Floating 32175060
Percent Insiders 1.96
Percent Institutions 93.03

Analyst Ratings

Rating 2.91
Target Price 96.17
Buy 1
Strong Buy -
Buy 1
Strong Buy -
Hold 9
Sell -
Strong Sell 1
Strong Sell 1

ai summary icon Upturn AI SWOT

Amedisys Inc

stock logo

Company Overview

overview logo History and Background

Amedisys Inc. was founded in 1982. Initially focused on providing home healthcare services in Louisiana, it expanded through acquisitions and organic growth, becoming a leading national provider of home health, hospice, and personal care services. Amedisys offers care to a broad range of patients needing recovery and long-term support.

business area logo Core Business Areas

  • Home Health: Provides skilled nursing, therapy services, and home health aides to patients in their homes. This segment is focused on helping patients recover from illness or injury and manage chronic conditions.
  • Hospice: Offers palliative care and support to patients with terminal illnesses and their families. This segment focuses on providing comfort and improving the quality of life for patients nearing the end of life.
  • Personal Care: Provides non-medical assistance with activities of daily living, such as bathing, dressing, and meal preparation. This segment serves patients who need help maintaining their independence at home.

leadership logo Leadership and Structure

The leadership team includes Chris Gerard (President & CEO), Scott Ginn (Chief Financial Officer), and members for each division. The organizational structure is based on the three core service lines: Home Health, Hospice, and Personal Care, with centralized support functions.

Top Products and Market Share

overview logo Key Offerings

  • Home Health Services: Includes skilled nursing, physical therapy, occupational therapy, speech therapy, and medical social services. Amedisys is a major player in this market with competitors such as LHC Group (LHCG) and Enhabit (EHAB). Specific market share for individual services is difficult to isolate.
  • Hospice Care: Encompasses palliative care, symptom management, emotional support, and spiritual care for terminally ill patients and their families. Key competitors include Gentiva and Compassus. Amedisys holds a significant share of the hospice market, but precise figures vary regionally.
  • Personal Care Services: Provides assistance with activities of daily living (ADLs) such as bathing, dressing, grooming, and meal preparation. Competitors in this sector include private-pay agencies and smaller regional providers. Market share data for personal care services is highly fragmented.

Market Dynamics

industry overview logo Industry Overview

The home health and hospice industry is experiencing growth due to the aging population, increasing prevalence of chronic diseases, and a shift towards value-based care. Technological advancements and regulatory changes are also shaping the industry landscape.

Positioning

Amedisys is a leading provider of home health and hospice care, distinguished by its national scale, comprehensive service offerings, and focus on quality and patient outcomes. Its competitive advantages include a strong brand reputation, established relationships with referral sources, and investment in technology to improve care delivery.

Total Addressable Market (TAM)

The TAM for home health and hospice care in the US is estimated to be several hundred billion dollars annually. Amedisys is well-positioned to capture a significant portion of this market with its diversified service offerings and expanding geographic footprint.

Upturn SWOT Analysis

Strengths

  • National Scale
  • Comprehensive Service Offerings
  • Strong Brand Reputation
  • Established Relationships with Referral Sources
  • Investment in Technology

Weaknesses

  • Labor Shortages
  • High Turnover Rates
  • Regulatory Compliance Challenges
  • Reimbursement Pressures
  • Integration Risks from Acquisitions

Opportunities

  • Aging Population
  • Increasing Prevalence of Chronic Diseases
  • Shift Towards Value-Based Care
  • Expansion into New Geographies
  • Partnerships with Healthcare Providers

Threats

  • Competition from Other Home Health and Hospice Providers
  • Changes in Government Reimbursement Policies
  • Rising Labor Costs
  • Increased Regulatory Scrutiny
  • Economic Downturn

Competitors and Market Share

competitor logo Key Competitors

  • LHCG
  • EHAB
  • GNTVA (Private)
  • COMPASSUS (Private)

Competitive Landscape

Amedisys competes with other national and regional home health and hospice providers. Its advantages include its scale, comprehensive service offerings, and strong brand reputation. Disadvantages include labor shortages and regulatory compliance challenges.

Major Acquisitions

Contessa Health

  • Year: 2021
  • Acquisition Price (USD millions): 250
  • Strategic Rationale: Expanded Amedisys' home-based acute care capabilities, allowing them to offer hospital-at-home services.

Growth Trajectory and Initiatives

Historical Growth: Amedisys has experienced significant growth through acquisitions and organic expansion. Revenue has steadily increased over the past decade, driven by demand for home health and hospice services.

Future Projections: Future growth is expected to be driven by the aging population and the increasing prevalence of chronic diseases, and is expected to continue increasing at a modest rate. Analyst estimates vary based on market conditions and company performance.

Recent Initiatives: Recent initiatives include investments in technology to improve care delivery, expansion into new geographies through acquisitions, and partnerships with healthcare providers to improve patient outcomes.

Summary

Amedisys is a strong player in the home health and hospice market, benefiting from the aging population and increasing demand for in-home care. Its national scale and comprehensive services provide a competitive edge, but the company faces challenges related to labor shortages and regulatory compliance. Strategic acquisitions and investments in technology should support future growth; however, the cost will add risk to the financials. Investors should watch how they integrate these purchases and how those impact revenue.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Filings (SEC)
  • Industry Reports
  • Analyst Estimates
  • Company Website

Disclaimers:

This analysis is based on publicly available information and analyst estimates. It is not financial advice, and investors should conduct their own due diligence before making investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Amedisys Inc

Exchange NASDAQ
Headquaters Baton Rouge, LA, United States
IPO Launch date 1994-08-17
President, CEO & Director Mr. Richard M. Ashworth
Sector Healthcare
Industry Medical Care Facilities
Full time employees 19000
Full time employees 19000

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.